NOVEL ENZYMATIC ABNORMALITIES IN AML AND CML IN BLAST CRISIS - ELEVATED LEUKOCYTE LEUKOTRIENE C-4 SYNTHASE ACTIVITY PARALLELED BY DEFICIENTLEUKOTRIENE BIOSYNTHESIS FROM ENDOGENOUS SUBSTRATE
L. Stenke et al., NOVEL ENZYMATIC ABNORMALITIES IN AML AND CML IN BLAST CRISIS - ELEVATED LEUKOCYTE LEUKOTRIENE C-4 SYNTHASE ACTIVITY PARALLELED BY DEFICIENTLEUKOTRIENE BIOSYNTHESIS FROM ENDOGENOUS SUBSTRATE, British Journal of Haematology, 101(4), 1998, pp. 728-736
Leukotrienes (LT) are inflammatory mediators which can also exert regu
latory effects on human myelopoiesis, We have studied the LT-producing
capacity of freshly isolated leucocyte suspensions (containing blast
cells in variable proportions) from 41 patients with acute myeloid leu
kaemia (AML) or chronic myeloid leukaemia (CML) in blast crisis (CMLbc
) at diagnosis or relapse/resistant disease. Leucocyte suspensions fro
m 19/29 AML patients (66%), and 2/12-CMLbc patients (17%; P=0.012) dem
onstrated deficient capacity to synthesize LT from endogenous substrat
e after ionophore A23187 stimulation. Thus, these cells produced <8pmo
l LTB4+LTC4/10(6) cells (<20% of mean LT formation in leucocyte suspen
sions from 18 healthy subjects). Addition of exogenous arachidonic aci
d did not normalize the LT synthesis in poor-producing cell suspension
s. Purified, morphologically mature granulocytes from two AML patients
also failed to produce normal amounts of LT. In leucocyte suspensions
from the remaining 20 AML/CMLbc patients A23187 provoked LT biosynthe
sis, with markedly increased production of LTC4, but decreased LTB4 fo
rmation. Furthermore, elevated conversion of exogenous LTA(4) to LTC4
was noted in the patient samples, independent of their capacity to pro
duce LT after A23187 stimulation. The percentage of blast cells in pat
ient white blood cell differential counts correlated inversely with io
nophore-induced LT synthesis, but positively with the conversion of ex
ogenous LTA4 to LTC4. The results suggest elevated LTC4 synthase activ
ity and suppressed 5-lipoxygenase activity as novel enzymatic features
of myeloid leukaemia patients with immature phenotype.